EXHIBIT 99.2
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in thousands of U.S. dollars) - unaudited
| | April 3, 2022 | | January 2, 2022 |
Current assets: | | | | | | | | |
Cash and cash equivalents | | $ | 121,575 | | | $ | 179,246 | |
Trade accounts receivable (note 4) | | | 460,694 | | | | 329,967 | |
Inventories (note 5) | | | 889,512 | | | | 774,358 | |
Prepaid expenses, deposits and other current assets | | | 181,734 | | | | 163,662 | |
Total current assets | | | 1,653,515 | | | | 1,447,233 | |
Non-current assets: | | | | | | | | |
Property, plant and equipment | | | 1,001,979 | | | | 985,073 | |
Right-of-use assets | | | 89,789 | | | | 92,447 | |
Intangible assets | | | 303,455 | | | | 306,630 | |
Goodwill | | | 283,815 | | | | 283,815 | |
Deferred income taxes | | | 13,730 | | | | 17,726 | |
Other non-current assets | | | 3,472 | | | | 3,758 | |
Total non-current assets | | | 1,696,240 | | | | 1,689,449 | |
Total assets | | $ | 3,349,755 | | | $ | 3,136,682 | |
Current liabilities: | | | | | | | | |
Accounts payable and accrued liabilities | | $ | 439,438 | | | $ | 440,401 | |
Income taxes payable | | | 11,237 | | | | 7,912 | |
Current portion of lease obligations (note 8(d)) | | | 14,550 | | | | 15,290 | |
Dividends payable | | | 31,966 | | | | — | |
Total current liabilities | | | 497,191 | | | | 463,603 | |
Non-current liabilities: | | | | | | | | |
Long-term debt (note 6) | | | 845,000 | | | | 600,000 | |
Lease obligations (note 8(d)) | | | 91,314 | | | | 93,812 | |
Other non-current liabilities | | | 58,913 | | | | 59,862 | |
Total non-current liabilities | | | 995,227 | | | | 753,674 | |
Total liabilities | | | 1,492,418 | | | | 1,217,277 | |
Equity: | | | | | | | | |
Share capital | | | 192,412 | | | | 191,732 | |
Contributed surplus | | | 58,979 | | | | 58,128 | |
Retained earnings | | | 1,517,951 | | | | 1,604,736 | |
Accumulated other comprehensive income | | | 87,995 | | | | 64,809 | |
Total equity attributable to shareholders of the Company | | | 1,857,337 | | | | 1,919,405 | |
Total liabilities and equity | | $ | 3,349,755 | | | $ | 3,136,682 | |
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q1 2022 35 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF EARNINGS
AND COMPREHENSIVE INCOME
(in thousands of U.S. dollars, except per share data) - unaudited
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Net sales (note 14) | | $ | 774,871 | | | $ | 589,585 | |
Cost of sales (note 8(e)) | | | 534,438 | | | | 401,071 | |
Gross profit | | | 240,433 | | | | 188,514 | |
Selling, general and administrative expenses | | | 80,513 | | | | 73,386 | |
Impairment (Reversal of impairment) of trade accounts receivable (note 4) | | | 496 | | | | (173 | ) |
Restructuring and acquisition-related (recovery) costs (note 7) | | | (2,794 | ) | | | 1,465 | |
Operating income | | | 162,218 | | | | 113,836 | |
Financial expenses, net (note 8(b)) | | | 7,014 | | | | 10,848 | |
Earnings before income taxes | | | 155,204 | | | | 102,988 | |
Income tax expense | | | 8,841 | | | | 4,447 | |
Net earnings | | | 146,363 | | | | 98,541 | |
Other comprehensive income, net of related income taxes (note 10): | | | | | | | | |
Cash flow hedges | | | 23,186 | | | | 99 | |
Comprehensive income | | $ | 169,549 | | | $ | 98,640 | |
Earnings per share (note 11): | | | | | | | | |
Basic | | $ | 0.77 | | | $ | 0.50 | |
Diluted | | $ | 0.77 | | | $ | 0.50 | |
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q1 2022 36 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Three months ended April 3, 2022 and April 4, 2021
(in thousands or thousands of U.S. dollars) - unaudited
| | Share capital | | | | | | | | |
| | Number | | Amount | | Contributed surplus | | Accumulated other comprehensive income (loss) | | Retained earnings | | Total equity |
Balance, January 2, 2022 | | | 192,267 | | | $ | 191,732 | | | $ | 58,128 | | | $ | 64,809 | | | $ | 1,604,736 | | | $ | 1,919,405 | |
Share-based compensation | | | — | | | | — | | | | 7,387 | | | | — | | | | — | | | | 7,387 | |
Shares issued under employee share purchase plan | | | 9 | | | | 331 | | | | — | | | | — | | | | — | | | | 331 | |
Shares issued pursuant to exercise of stock options | | | 43 | | | | 1,343 | | | | (327 | ) | | | — | | | | — | | | | 1,016 | |
Shares issued or distributed pursuant to vesting of restricted share units | | | 150 | | | | 4,255 | | | | (8,319 | ) | | | — | | | | — | | | | (4,064 | ) |
Shares repurchased for cancellation | | | (5,135 | ) | | | (5,133 | ) | | | — | | | | — | | | | (196,104 | ) | | | (201,237 | ) |
Share repurchases for settlement of non-Treasury RSUs | | | (148 | ) | | | (116 | ) | | | — | | | | — | | | | (5,593 | ) | | | (5,709 | ) |
Deferred compensation to be settled in non-Treasury RSUs | | | — | | | | — | | | | 2,110 | | | | — | | | | — | | | | 2,110 | |
Dividends declared | | | — | | | | — | | | | — | | | | — | | | | (31,451 | ) | | | (31,451 | ) |
Transactions with shareholders of the Company recognized directly in equity | | | (5,081 | ) | | | 680 | | | | 851 | | | | — | | | | (233,148 | ) | | | (231,617 | ) |
Cash flow hedges (note 10) | | | — | | | | — | | | | — | | | | 23,186 | | | | — | | | | 23,186 | |
Net earnings | | | — | | | | — | | | | — | | | | — | | | | 146,363 | | | | 146,363 | |
Comprehensive income | | | — | | | | — | | | | — | | | | 23,186 | | | | 146,363 | | | | 169,549 | |
Balance, April 3, 2022 | | | 187,186 | | | $ | 192,412 | | | $ | 58,979 | | | $ | 87,995 | | | $ | 1,517,951 | | | $ | 1,857,337 | |
Balance, January 3, 2021 | | | 198,407 | | | $ | 183,938 | | | $ | 24,936 | | | $ | (9,038 | ) | | $ | 1,359,061 | | | $ | 1,558,897 | |
Share-based compensation | | | — | | | | — | | | | 7,754 | | | | — | | | | — | | | | 7,754 | |
Shares issued under employee share purchase plan | | | 11 | | | | 315 | | | | — | | | | — | | | | — | | | | 315 | |
Shares issued or distributed pursuant to vesting of restricted share units | | | 66 | | | | 1,978 | | | | (3,457 | ) | | | — | | | | — | | | | (1,479 | ) |
Share repurchases for settlement of non-Treasury RSUs | | | (65 | ) | | | (47 | ) | | | — | | | | — | | | | (1,710 | ) | | | (1,757 | ) |
Deferred compensation to be settled in non-Treasury RSUs | | | — | | | | — | | | | 2,197 | | | | — | | | | — | | | | 2,197 | |
Transactions with shareholders of the Company recognized directly in equity | | | 12 | | | | 2,246 | | | | 6,494 | | | | — | | | | (1,710 | ) | | | 7,030 | |
Cash flow hedges (note 10) | | | — | | | | — | | | | — | | | | 99 | | | | — | | | | 99 | |
Net earnings | | | — | | | | — | | | | — | | | | — | | | | 98,541 | | | | 98,541 | |
Comprehensive income | | | — | | | | — | | | | — | | | | 99 | | | | 98,541 | | | | 98,640 | |
Balance, April 4, 2021 | | | 198,419 | | | $ | 186,184 | | | $ | 31,430 | | | $ | (8,939 | ) | | $ | 1,455,892 | | | $ | 1,664,567 | |
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q1 2022 37 |
| CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |
GILDAN ACTIVEWEAR INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands of U.S. dollars) - unaudited
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Cash flows from (used in) operating activities: | | | | | | | | |
Net earnings | | $ | 146,363 | | | $ | 98,541 | |
Adjustments for: | | | | | | | | |
Depreciation and amortization (note 8(a)) | | | 33,456 | | | | 35,626 | |
Non-cash restructuring gains related to property, plant and equipment, right-of-use assets, and computer software (note 7) | | | (3,877 | ) | | | (245 | ) |
Insurance recovery gain, net of loss on disposal of property, plant and equipment(1) | | | (2,365 | ) | | | (7,585 | ) |
Share-based compensation | | | 7,420 | | | | 7,786 | |
Other (note 12(a)) | | | 3,849 | | | | (9,854 | ) |
Changes in non-cash working capital balances (note 12(c))(1) | | | (236,311 | ) | | | (103,674 | ) |
Cash flows (used in) from operating activities | | | (51,465 | ) | | | 20,595 | |
| | | | | | | | |
Cash flows from (used in) investing activities: | | | | | | | | |
Purchase of property, plant and equipment | | | (32,081 | ) | | | (12,752 | ) |
Purchase of intangible assets | | | (1,909 | ) | | | (283 | ) |
Proceeds from insurance related to property, plant and equipment (PP&E) and other disposals of PP&E | | | (2 | ) | | | 30,000 | |
Cash flows (used in) from investing activities | | | (33,992 | ) | | | 16,965 | |
| | | | | | | | |
Cash flows from (used in) financing activities: | | | | | | | | |
Increase in amounts drawn under long-term bank credit facility | | | 245,000 | | | | — | |
Payment of lease obligations | | | (4,632 | ) | | | (4,991 | ) |
Proceeds from the issuance of shares | | | 1,314 | | | | 283 | |
Repurchase and cancellation of shares | | | (204,653 | ) | | | — | |
Share repurchases for settlement of non-Treasury RSUs | | | (5,709 | ) | | | (1,757 | ) |
Withholding taxes paid pursuant to the settlement of non-Treasury RSUs | | | (4,064 | ) | | | — | |
Cash flows from (used in) financing activities | | | 27,256 | | | | (6,465 | ) |
| | | | | | | | |
Effect of exchange rate changes on cash and cash equivalents denominated in foreign currencies | | | 530 | | | | (323 | ) |
(Decrease) Increase in cash and cash equivalents during the period | | | (57,671 | ) | | | 30,772 | |
Cash and cash equivalents, beginning of period | | | 179,246 | | | | 505,264 | |
Cash and cash equivalents, end of period | | $ | 121,575 | | | $ | 536,036 | |
| | | | | | | | |
Cash paid during the period (included in cash flows from (used in) operating activities): | | | | | | | | |
Interest | | $ | 6,110 | | | $ | 9,232 | |
Income taxes, net of refunds | | | 1,577 | | | | 157 | |
(1) The Company restated comparative figures to conform to the current period's presentation by reclassifying $12 million from changes in non-cash working capital balances, prepaid expenses, deposits and other current assets, to insurance recovery gain, net of loss on disposal of property, plant and equipment, for a net impact of nil on total cash flows from operating activities.
Supplemental disclosure of cash flow information (note 12).
See accompanying notes to unaudited condensed interim consolidated financial statements.
QUARTERLY REPORT - Q1 2022 38 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
For the period ended April 3, 2022
(Tabular amounts in thousands or thousands of U.S. dollars except per share data, unless otherwise indicated)
1. REPORTING ENTITY:
Gildan Activewear Inc. (the "Company" or "Gildan") is domiciled in Canada and is incorporated under the Canada Business Corporations Act. Its principal business activity is the manufacture and sale of activewear, hosiery, and underwear. The Company’s fiscal year ends on the Sunday closest to December 31 of each year.
The address of the Company’s registered office is 600 de Maisonneuve Boulevard West, Suite 3300, Montreal, Quebec. These unaudited condensed interim consolidated financial statements are as at and for the three months ended April 3, 2022 and include the accounts of the Company and its subsidiaries. The Company is a publicly listed entity and its shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol GIL.
2. BASIS OF PREPARATION:
(a) Statement of compliance:
These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting, as issued by the International Accounting Standards Board (“IASB”). These unaudited condensed interim consolidated financial statements should be read in conjunction with the Company’s fiscal 2021 audited consolidated financial statements. The Company applied the same accounting policies in the preparation of these unaudited condensed interim consolidated financial statements as those disclosed in note 3 of its most recent annual consolidated financial statements.
These unaudited condensed interim consolidated financial statements were authorized for issuance by the Board of Directors of the Company on May 4, 2022.
(b) Seasonality of the business:
The Company’s net sales are subject to seasonal variations. Net sales have historically been higher during the second and third quarters.
(c) Operating segments:
The Company manages its business on the basis of one reportable operating segment.
QUARTERLY REPORT - Q1 2022 39 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
3. NEW ACCOUNTING STANDARDS AND INTERPRETATIONS NOT YET APPLIED:
Amendments to IAS 1, Presentation of Financial Statements
On January 23, 2020, the IASB issued narrow-scope amendments to IAS 1, Presentation of Financial Statements, to clarify how to classify debt and other liabilities as current or non-current. The amendments (which affect only the presentation of liabilities in the statement of financial position) clarify that the classification of liabilities as current or non-current should be based on rights that are in existence at the end of the reporting period to defer settlement by at least twelve months and make explicit that only rights in place at the end of the reporting period should affect the classification of a liability; clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability; and make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets, or services. The amendments are effective for annual reporting periods beginning on or after January 1, 2023 and are to be applied retrospectively. Earlier application is permitted. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
Amendments to IAS 1 and IFRS Practice Statement 2, Disclosure of Accounting Policy Information
In February 2021, the IASB issued amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements. The amendments help entities provide accounting policy disclosures that are more useful to primary users of financial statements by:
| – | Replacing the requirement to disclose “significant” accounting policies under IAS 1 with a requirement to disclose “material” accounting policies. Under this, an accounting policy would be material if, when considered together with other information included in an entity’s financial statements, it can reasonably be expected to influence decisions that primary users of general purpose financial statements make on the basis of those financial statements. |
| – | Providing guidance in IFRS Practice Statement 2 to explain and demonstrate the application of the four-step materiality process to accounting policy disclosures. |
The amendments shall be applied prospectively. The amendments to IAS 1 are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. Once an entity applies the amendments to IAS 1, it is also permitted to apply the amendments to IFRS Practice Statement 2. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
Amendments to IAS 8, Definition of Accounting Estimates
In February 2021, the IASB amended IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors to introduce a new definition of “accounting estimates” to replace the definition of “change in accounting estimates” and also include clarifications intended to help entities distinguish changes in accounting policies from changes in accounting estimates. This distinction is important because changes in accounting policies must be applied retrospectively while changes in accounting estimates are accounted for prospectively. The amendments are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single Transaction
On May 7, 2021, the IASB amended IAS 12 Income Taxes, to narrow the scope of the initial recognition exemption so that it does not apply to transactions that give rise to equal and offsetting temporary differences. The amendments are effective for annual periods beginning on or after January 1, 2023. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
QUARTERLY REPORT - Q1 2022 40 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
4. TRADE ACCOUNTS RECEIVABLE:
| | April 3, 2022 | | January 2, 2022 |
Trade accounts receivable | | $ | 475,009 | | | $ | 343,671 | |
Allowance for expected credit losses | | | (14,315 | ) | | | (13,704 | ) |
| | $ | 460,694 | | | $ | 329,967 | |
As at April 3, 2022, trade accounts receivables being serviced under a receivables purchase agreement amounted to $102.1 million (January 2, 2022 - $144.9 million). The receivables purchase agreement, which allows for the sale of a maximum of $225 million of accounts receivables at any one time, expires on June 19, 2023, subject to annual extensions. The Company retains servicing responsibilities, including collection, for these trade receivables but has not retained any credit risk with respect to any trade receivables that have been sold. The difference between the carrying amount of the receivables sold under the agreement and the cash received at the time of transfer was $0.4 million (2021 - $0.4 million) for the three months ended April 3, 2022, and was recorded in bank and other financial charges.
The movement in the allowance for expected credit losses in respect of trade receivables was as follows:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Allowance for expected credit losses, beginning of period | | $ | (13,704 | ) | | $ | (18,994 | ) |
(Impairment) Reversal of impairment of trade accounts receivable | | | (496 | ) | | | 173 | |
Recoveries of trade accounts receivable | | | (115 | ) | | | (138 | ) |
Allowance for expected credit losses, end of period | | $ | (14,315 | ) | | $ | (18,959 | ) |
5. INVENTORIES:
| | April 3, 2022 | | January 2, 2022 |
Raw materials and spare parts inventories | | $ | 195,766 | | | $ | 183,065 | |
Work in progress | | | 76,532 | | | | 53,482 | |
Finished goods | | | 617,214 | | | | 537,811 | |
| | $ | 889,512 | | | $ | 774,358 | |
QUARTERLY REPORT - Q1 2022 41 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
6. LONG-TERM DEBT:
| | | | | | | Principal amount | | | |
| | | Effective interest rate(1) | | | | April 3, 2022 | | | | January 2, 2022 | | | Maturity date |
Revolving long-term bank credit facility, interest at variable U.S. interest rate(2)(3) | | | 1.3 | % | | $ | 245,000 | | | $ | — | | | March 2027 |
Term loan, interest at variable U.S. interest rate, payable monthly(2)(4) | | | 2.1 | % | | | 300,000 | | | | 300,000 | | | June 2026 |
Notes payable, interest at fixed rate of 2.70%, payable semi-annually(5) | | | 2.7 | % | | | 100,000 | | | | 100,000 | | | August 2023 |
Notes payable, interest at variable U.S. LIBOR-based interest rate plus a spread of 1.53%, payable quarterly(5) | | | 2.7 | % | | | 50,000 | | | | 50,000 | | | August 2023 |
Notes payable, interest at fixed rate of 2.91%, payable semi-annually(5) | | | 2.9 | % | | | 100,000 | | | | 100,000 | | | August 2026 |
Notes payable, interest at variable U.S. LIBOR-based interest rate plus a spread of 1.57%, payable quarterly(5) | | | 2.9 | % | | | 50,000 | | | | 50,000 | | | August 2026 |
| | | | | | $ | 845,000 | | | $ | 600,000 | | | |
| (1) | Represents the annualized effective interest rate for the three months ended April 3, 2022, including the cash impact of interest rate swaps, where applicable. |
| (2) | LIBOR advances at variable U.S. LIBOR-based interest rates or SOFR advances at Adjusted Term SOFR (includes a 0% to 0.25% reference rate adjustment) plus a spread ranging from 1% to 3%. |
| (3) | The Company’s committed unsecured revolving long-term bank credit facility of $1 billion provides for an annual extension which is subject to the approval of the lenders. The spread added to the U.S. LIBOR-based variable interest rate or to the Adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the credit facility agreement and its amendments). In addition, an amount of $45.7 million (January 2, 2022 - $51.1 million) has been committed against this facility to cover various letters of credit. |
| (4) | The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to the U.S. LIBOR-based variable interest rate or to the Adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments). |
| (5) | The unsecured notes issued for a total aggregate principal amount of $300 million to accredited investors in the U.S. private placement market can be prepaid in whole or in part at any time subject to the payment of a prepayment penalty as provided for in the Note Purchase Agreement. |
On April 20, 2021, the Company fully repaid its $400 million unsecured two-year term loan which was due on April 6, 2022. In June 2021, the Company amended its unsecured term loan of $300 million to extend the maturity date from April 2025 to June 2026.
On March 25, 2022, the Company amended and extended its unsecured revolving long-term bank credit facility of $1 billion to March 2027. As part of the amendment, the Company transitioned its revolving facility into a sustainability-linked loan ("SLL") structure, whereby its applicable margins are adjusted upon achievement of certain sustainability targets, commencing in 2023. The amendments also replace LIBOR references by Term Secured Overnight Financing Rate (‘‘Term SOFR’’). Revolving facility advances made prior to these amendments continue to apply LIBOR rates until the end of their term.
On March 25, 2022, the Company amended its $300 million term loan to replace LIBOR references by Term SOFR references.
The Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap agreements. The Company continues to have discussions with its lenders to amend its existing unsecured notes agreement to include LIBOR fallback provisions.
The Company was in compliance with all financial covenants at April 3, 2022 and expects to maintain compliance with its covenants over the next twelve months, based on its current expectations and forecasts.
QUARTERLY REPORT - Q1 2022 42 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
7. RESTRUCTURING AND ACQUISITION-RELATED (RECOVERY) COSTS:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Employee termination and benefit costs | | $ | 584 | | | $ | — | |
Exit, relocation and other costs | | | 394 | | | | 1,710 | |
Net gain on disposal, write-downs, and accelerated depreciation of property, plant and equipment, right-of-use assets and computer software related to exit activities | | | (3,877 | ) | | | (245 | ) |
Acquisition-related transaction costs | | | 105 | | | | — | |
| | $ | (2,794 | ) | | $ | 1,465 | |
Restructuring and acquisition-related recovery for the three months ended April 3, 2022 mainly related to a gain of $3.4 million on the sale of a former manufacturing facility in Mexico, partly offset by $0.6 million in employee termination and benefit costs related to the pending closure of a distribution centre in the U.S.
Restructuring and acquisition-related costs for the three months ended April 4, 2021 mainly related to the completion of previously initiated restructuring activities.
8. OTHER INFORMATION:
(a) Depreciation and amortization:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Depreciation of property, plant and equipment | | $ | 25,502 | | | $ | 23,116 | |
Depreciation of right-of-use assets | | | 3,948 | | | | 3,758 | |
Adjustment for the variation of depreciation included in inventories at the beginning and end of the period | | | (838 | ) | | | 4,079 | |
Amortization of intangible assets, excluding computer software | | | 3,444 | | | | 3,307 | |
Amortization of computer software | | | 1,400 | | | | 1,366 | |
Depreciation and amortization included in net earnings | | $ | 33,456 | | | $ | 35,626 | |
Included in property, plant and equipment as at April 3, 2022 is $75.4 million (January 2, 2022 - $76.7 million) of buildings and equipment not yet available for use in operations. Included in intangible assets as at April 3, 2022 is $2.5 million (January 2, 2022 - $3.6 million) of software not yet available for use in operations. Depreciation and amortization on these assets commence when the assets are available for use.
Effective January 3, 2022, the Company revised the estimated useful life of certain Textile & Sewing manufacturing equipment based on a re-assessment of their expected use to the Company and recent experience of their economic life. These assets, which were previously being depreciated on straight-line basis over 10 years, will be depreciated on a straight-line basis over 15 years. The change in estimate has been made on a prospective basis. For the year ending January 1, 2023, the change in estimate is expected to result in a reduction of depreciation included in net earnings of approximately $5 million.
As at April 3, 2022, the Company has approximately $250 million in commitments to purchase property and equipment, mainly related to manufacturing capacity expansion projects.
QUARTERLY REPORT - Q1 2022 43 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
8. OTHER INFORMATION (continued):
(b) Financial expenses, net:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Interest expense on financial liabilities recorded at amortized cost(1) | | $ | 3,775 | | | $ | 6,351 | |
Bank and other financial charges | | | 1,787 | | | | 3,269 | |
Interest accretion on discounted lease obligations | | | 788 | | | | 725 | |
Interest accretion on discounted provisions | | | 51 | | | | 35 | |
Foreign exchange loss | | | 613 | | | | 468 | |
| | $ | 7,014 | | | $ | 10,848 | |
(1) Net of capitalized borrowing costs of $0.3 million (2021 - $0.4 million) for the three months ended April 3, 2022.
(c) Related party transaction:
The Company incurred expenses for airplane usage of $0.9 million (2021 - $0.1 million), for the three months ended April 3, 2022, with a company controlled by the President and Chief Executive Officer of the Company. The payments made are in accordance with the terms of the agreement established and agreed to by the related parties. As at April 3, 2022, the amount in accounts payable and accrued liabilities related to the airplane usage was $0.9 million (January 2, 2022 - $0.3 million).
As at April 3, 2022, the Company has a commitment of $0.5 million under this agreement, which relates to minimum usage fees for the remainder of fiscal 2022.
(d) Lease obligations:
The Company’s leases are primarily for manufacturing, sales, distribution, and administrative facilities.
The following table presents lease obligations recorded in the statement of financial position:
| | April 3, 2022 | | January 2, 2022 |
Current | | | $ | 14,550 | | | $ | 15,290 | |
Non-current | | | | 91,314 | | | | 93,812 | |
| | | | $ | 105,864 | | | $ | 109,102 | |
The following table presents the future minimum lease payments under non-cancellable leases (including short-term leases) as at April 3, 2022:
| | April 3, 2022 |
Less than one year | | $ | 19,985 | |
One to five years | | | 52,382 | |
More than five years | | | 58,658 | |
| | $ | 131,025 | |
For the three months ended April 3, 2022, the total cash outflow for recognized lease obligations (including interest) was $5.4 million (2021 - $5.7 million), of which $4.6 million (2021 - $5.0 million) was included as part of cash outflows used in financing activities.
QUARTERLY REPORT - Q1 2022 44 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
8. OTHER INFORMATION (continued):
(e) Cost of sales:
Included in cost of sales for the three months ended April 3, 2022 are the following items:
| • | Net insurance gains of $0.3 million for the three months ended April 3, 2022, related to the two hurricanes which occurred in Central America in November 2020. The net insurance gains reflected costs of $4.4 million for the three months ended April 3, 2022, (mainly attributable to equipment repairs, and other costs and charges), which were more than offset by related accrued insurance recoveries of $4.7 million for the three months ended April 3, 2022. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of the net book value of property plant and equipment. |
Since November 2020, the Company has recognized $217.4 million of accrued insurance recoveries, of which $200.0 million has been received as an advance ($50.0 million in December 2020, $50.0 million in March 2021, $50.0 million in June 2021 and $50.0 million in September 2021). As at April 3, 2022, $17.4 million of insurance recoveries receivable are recorded in prepaid expenses, deposits and other current assets in the consolidated statement of financial position.
The Company recognizes insurance recoveries for items that it has an unconditional contractual right to receive. The Company expects to recognize additional insurance recoveries as the insurance claim process progresses.
| • | A gain of $1.0 million related to the reversal of a reserve relating to Company's strategic initiatives to significantly reduce its product line stock-keeping unit (SKU) counts. |
Included in cost of sales for the three months ended April 4, 2021 are the following items:
| • | A $17.9 million reduction of cost of sales related to pandemic government assistance for users of U.S. cotton. |
| • | A net gain of $6.2 million related to the two hurricanes which occurred in Central America in November 2020, consisting of accrued insurance recoveries of $30.5 million, partially offset by the following related costs totaling $24.3 million: |
| – | $4.4 million of losses on disposal of unrepairable equipment; |
| – | $17.2 million of equipment repairs, salary and benefits continuation for idle employees, and other costs; and |
| – | $2.7 million of unabsorbed salary, benefits, and overhead costs, including depreciation that resulted from production interruptions related to the two hurricanes. |
As at April 4, 2021, $41.5 million of insurance recoveries receivable were recorded in prepaid expenses, deposits and other current assets in the consolidated statement of financial position.
| • | Charges of $1.2 million related to the Company’s strategic initiatives to significantly reduce its product line stock-keeping unit (SKU) counts. |
QUARTERLY REPORT - Q1 2022 45 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
9. FAIR VALUE MEASUREMENT:
Financial instruments – carrying amounts and fair values:
The carrying amounts and fair values of financial assets and liabilities included in the unaudited condensed interim consolidated statements of financial position are as follows:
| | April 3, 2022 | | January 2, 2022 |
Financial assets | | | | | | | | |
Amortized cost: | | | | | | | | |
Cash and cash equivalents | | $ | 121,575 | | | $ | 179,246 | |
Trade accounts receivable | | | 460,694 | | | | 329,967 | |
Financial assets included in prepaid expenses, deposits and other current assets | | | 69,356 | | | | 69,995 | |
Long-term non-trade receivables included in other non-current assets | | | 324 | | | | 390 | |
Derivative financial assets included in prepaid expenses, deposits and other current assets | | | 84,428 | | | | 62,758 | |
Financial liabilities | | | | | | | | |
Amortized cost: | | | | | | | | |
Accounts payable and accrued liabilities(1) | | | 436,069 | | | | 436,073 | |
Dividend payable | | | 31,966 | | | | — | |
Long-term debt - bearing interest at variable rates | | | 645,000 | | | | 400,000 | |
Long-term debt - bearing interest at fixed rates(2) | | | 200,000 | | | | 200,000 | |
Derivative financial liabilities included in accounts payable and accrued liabilities | | | 3,369 | | | | 4,328 | |
(1) Accounts payable and accrued liabilities include $22.9 million (January 2, 2022 - $18.1 million) under supply-chain financing arrangements (reverse factoring) with a financial institution, whereby receivables due from the Company to certain suppliers can be collected by the suppliers from a financial institution before their original due date. These balances are classified as accounts payable and accrued liabilities and the related payments as cash flows from operating activities, given the principal business purpose of the arrangement is to provide funding to the supplier and not the Company, the arrangement does not significantly extend the payment terms beyond the normal terms agreed with other suppliers, and no additional deferral or special guarantees to secure the payments are included in the arrangement. Accounts payable and accrued liabilities also include balances payable of $24.4 million (January 2, 2022 - $48.8 million) resulting mainly from a one-week timing difference between the collection of sold receivables and the weekly remittance to our bank counterparty under our receivables purchase agreement that is disclosed in note 4 to these consolidated financial statements.
(2) The fair value of the long-term debt bearing interest at fixed rates was $203.5 million as at April 3, 2022 (January 2, 2022 - $212.2 million).
Short-term financial assets and liabilities
The Company has determined that the fair value of its short-term financial assets and liabilities approximates their respective carrying amounts as at the reporting dates due to the short-term maturities of these instruments, as they bear variable interest-rates, or because the terms and conditions are comparable to current market terms and conditions for similar items.
Non-current assets and long-term debt bearing interest at variable rates
The fair values of the long-term non-trade receivables included in other non-current assets and the Company’s long-term debt bearing interest at variable rates also approximate their respective carrying amounts because the interest rates applied to measure their carrying amounts approximate current market interest rates.
Long-term debt bearing interest at fixed rates
The fair value of the long-term debt bearing interest at fixed rates is determined using the discounted future cash flows method and at discount rates based on yield to maturities for similar issuances. The fair value of the long-term debt bearing interest at fixed rates was measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of the long-term debt bearing interest at fixed rates, the Company takes into account its own credit risk and the credit risk of the counterparties.
QUARTERLY REPORT - Q1 2022 46 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
9. FAIR VALUE MEASUREMENT (continued):
Derivatives
Derivative financial instruments are designated as effective hedging instruments and consist of foreign exchange and commodity forward, option, and swap contracts, as well as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes. The fair value of the forward contracts is measured using a generally accepted valuation technique which is the discounted value of the difference between the contract’s value at maturity based on the rate set out in the contract and the contract’s value at maturity based on the rate that the counterparty would use if it were to renegotiate the same contract terms at the measurement date under current conditions. The fair value of the option contracts is measured using option pricing models that utilize a variety of inputs that are a combination of quoted prices and market-corroborated inputs, including volatility estimates and option adjusted credit spreads. The fair value of the interest rate swaps is determined based on market data, by measuring the difference between the fixed contracted rate and the forward curve for the applicable floating interest rates.
The Company also has a total return swap (“TRS”) outstanding that is intended to reduce the variability of net earnings associated with deferred share units, which are settled in cash. The TRS is not designated as a hedging instrument and, therefore, the fair value adjustment at the end of each reporting period is recognized in selling, general and administrative expenses. The fair value of the TRS is measured by reference to the market price of the Company’s common shares, at each reporting date. The TRS has a one-year term, may be extended annually, and the contract allows for early termination at the option of the Company. As at April 3, 2022, the notional amount of TRS outstanding was 319,639 shares.
Derivative financial instruments were measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of derivative financial instruments the Company takes into account its own credit risk and the credit risk of the counterparties.
QUARTERLY REPORT - Q1 2022 47 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
10. OTHER COMPREHENSIVE INCOME (“OCI”):
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Net gain (loss) on derivatives designated as cash flow hedges: | | |
Foreign currency risk | | $ | 2,116 | | | $ | (516 | ) |
Commodity price risk | | | 44,958 | | | | 2,834 | |
Interest rate risk | | | 10,834 | | | | 4,148 | |
Income taxes | | | (21 | ) | | | 5 | |
Amounts reclassified from OCI to inventory, related to commodity price risk | | | (32,589 | ) | | | (8,874 | ) |
Amounts reclassified from OCI to net earnings, related to foreign currency risk, interest rate risk, and commodity risk, and included in: | | | | | | | | |
Net sales | | | (1,739 | ) | | | 1,620 | |
Cost of sales | | | — | | | | — | |
Selling, general and administrative expenses | | | 14 | | | | (458 | ) |
Financial expenses, net | | | (408 | ) | | | 1,365 | |
Income taxes | | | 21 | | | | (25 | ) |
Other comprehensive income | | $ | 23,186 | | | $ | 99 | |
The change in the time value element of option and swap contracts designated as cash flow hedges to reduce the exposure in movements of commodity prices was not significant for the three months ended April 3, 2022 and for the three months ended April 4, 2021. The change in the forward element of derivatives designated as cash flow hedges to reduce foreign currency risk was not significant for the three months ended April 3, 2022 and for the three months ended April 4, 2021. No ineffectiveness has been recognized in net earnings for the three months ended April 3, 2022 and for the three months ended April 4, 2021.
As at April 3, 2022, accumulated other comprehensive income of $88.0 million consisted of net deferred gains on commodity forward, option, and swap contracts of $77.2 million, net deferred gains on interest rate swap contracts of $8.3 million, and net deferred gains on forward foreign exchange contracts of $2.5 million. Approximately $79.9 million of net gains presented in accumulated other comprehensive income are expected to be reclassified to inventory or net earnings within the next twelve months.
QUARTERLY REPORT - Q1 2022 48 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
11. EARNINGS PER SHARE:
Reconciliation between basic and diluted earnings per share is as follows:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Net earnings - basic and diluted | | $ | 146,363 | | | $ | 98,541 | |
Basic earnings per share: | | | | | | | | |
Basic weighted average number of common shares outstanding | | | 189,344 | | | | 198,418 | |
Basic earnings per share | | $ | 0.77 | | | $ | 0.50 | |
Diluted earnings per share: | | | | | | | | |
Basic weighted average number of common shares outstanding | | | 189,344 | | | | 198,418 | |
Plus dilutive impact of stock options, Treasury RSUs and common shares held in trust | | | 870 | | | | 164 | |
Diluted weighted average number of common shares outstanding | | | 190,214 | | | | 198,582 | |
Diluted earnings per share | | $ | 0.77 | | | $ | 0.50 | |
Excluded from the above calculation for the three months ended April 3, 2022 are nil stock options (2021 - 2,312,933) and nil Treasury RSUs (2021 - nil) which were deemed to be anti-dilutive.
QUARTERLY REPORT - Q1 2022 49 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
12. SUPPLEMENTAL CASH FLOW DISCLOSURE:
(a) Adjustments to reconcile net earnings to cash flows from (used in) operating activities - other items:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Deferred income taxes | | $ | 4,000 | | | $ | 1,200 | |
Unrealized net gain on foreign exchange and financial derivatives | | | (265 | ) | | | (5,180 | ) |
Timing differences between settlement of financial derivatives and transfer of deferred gains and losses in accumulated OCI to inventory and net earnings | | | 1,279 | | | | (3,984 | ) |
Other non-current assets | | | 286 | | | | 871 | |
Other non-current liabilities | | | (1,451 | ) | | | (2,761 | ) |
| | $ | 3,849 | | | $ | (9,854 | ) |
(b) Variations in non-cash transactions:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Dividend payable | | $ | 31,451 | | | $ | — | |
Shares repurchased for cancellation included in accounts payable and accrued liabilities | | | (3,416 | ) | | | — | |
Additions to property, plant and equipment and intangible assets included in accounts payable and accrued liabilities | | | 6,188 | | | | 1,054 | |
Proceeds on disposal of property, plant and equipment and computer software included in other current assets | | | (2 | ) | | | (105 | ) |
Additions to right-of-use assets included in lease obligations | | | 1,288 | | | | — | |
Non-cash ascribed value credited to share capital from shares issued or distributed pursuant to vesting of restricted share units and exercise of stock options | | | 4,582 | | | | 1,978 | |
Deferred compensation credited to contributed surplus | | | (2,110 | ) | | | (2,197 | ) |
(c) Changes in non-cash working capital balances:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Trade accounts receivable | | $ | (130,348 | ) | | $ | (72,452 | ) |
Income taxes | | | 3,265 | | | | 3,082 | |
Inventories | | | (114,316 | ) | | | (12,496 | ) |
Prepaid expenses, deposits and other current assets | | | 5,930 | | | | (21,011 | ) |
Accounts payable and accrued liabilities | | | (842 | ) | | | (797 | ) |
| | $ | (236,311 | ) | | $ | (103,674 | ) |
QUARTERLY REPORT - Q1 2022 50 |
| NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |
13. CONTINGENT LIABILITIES:
Claims and litigation
The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect the resolution of these matters to have a material adverse effect on the financial position or results of operations of the Company.
14. DISAGGREGATION OF REVENUE:
Net sales by major product group were as follows:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
Activewear | | $ | 667,260 | | | $ | 484,611 | |
Hosiery and underwear | | | 107,611 | | | | 104,974 | |
| | $ | 774,871 | | | $ | 589,585 | |
Net sales were derived from customers located in the following geographic areas:
| | Three months ended |
| | April 3, 2022 | | April 4, 2021 |
United States | | $ | 681,820 | | | $ | 506,820 | |
Canada | | | 30,194 | | | | 22,594 | |
International | | | 62,857 | | | | 60,171 | |
| | $ | 774,871 | | | $ | 589,585 | |
QUARTERLY REPORT - Q1 2022 51 |